NCT05924789 Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America Status COMPLETED Phase N/A
NCT05717998 Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation Therapy Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05620134 Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05438940 Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients Status ACTIVE_NOT_RECRUITING Phase NA
NCT05431738 Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG) Status RECRUITING Phase NA
NCT05395052 FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT05379972 Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05338060 A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer Status COMPLETED Phase N/A
NCT05205343 Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers Status RECRUITING Phase N/A
NCT05122091 Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma Status RECRUITING Phase PHASE2
NCT04688801 Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer Status RECRUITING Phase NA
NCT04681248 Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors Status NO_LONGER_AVAILABLE Phase N/A
NCT04602117 ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer Status WITHDRAWN Phase PHASE1
NCT04555304 Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy Status UNKNOWN Phase PHASE2
NCT04510285 A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection Status TERMINATED Phase PHASE2
NCT04504669 First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours Status COMPLETED Phase PHASE1
NCT04385641 Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer Status UNKNOWN Phase NA
NCT04363801 A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer Status TERMINATED Phase PHASE2